374 filings
Page 2 of 19
8-K
yz4vn
14 Feb 24
Entry into a Material Definitive Agreement
4:30pm
8-K
jttu wiq4kmvdqa9c
14 Feb 24
Entry into a Material Definitive Agreement
6:03am
8-K
y37 i234opsia
2 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:37pm
8-K
6rw14xrt2wrzmk fn
23 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
3
uygmal
16 Jan 24
NRX Pharmaceuticals / Janet Rehnquist ownership change
6:36pm
8-K
hhcxy09798 nmr0
29 Dec 23
Departure of Directors or Certain Officers
4:15pm
8-K
rm2n dzjv17qowy
21 Dec 23
Other Events
4:05pm
ARS
pzj8x3sz
22 Nov 23
Annual report to shareholders
4:32pm
8-K/A
4qfihy0c0qk9lwlyt bo
22 Nov 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
oh398k48j9x89w7kca4x
21 Nov 23
Changes in Registrant's Certifying Accountant
5:23pm
8-K
n32c27
14 Nov 23
NRx Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
tzyes7txkob
23 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
3
8rm6aafstpti1x27
19 Sep 23
NRX Pharmaceuticals / Richard Clavano Narido ownership change
4:05pm
8-K
trv4frks ihwrvrjfsz
14 Sep 23
NRx Pharmaceuticals Announces Agreement with LifeSci Associates to Provide Financial Services and Support
4:04pm
4
m3bcw3s2ov6m3asfix
11 Sep 23
NRX Pharmaceuticals / Aaron Gorovitz ownership change
9:19am
4
d7y6fo
11 Sep 23
NRX Pharmaceuticals / Chaim Hurvitz ownership change
9:15am
8-K
y3slh kshvsw
1 Sep 23
NRx Pharmaceuticals Announces Definitive Purchase Agreement for Preferred Shares at $0.40 per share
4:48pm